IBS-C questionnaire study

Study identifier:D5630R00002

ClinicalTrials.gov identifier:NCT04968652

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Evaluation of the Simplified Diagnosis Tool for Chinese IBS-C (irritable bowel syndrome with constipation) patients

Medical condition

irritable bowel syndrome with constipation

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

327

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 01 Nov 2021
Primary Completion Date: 28 Oct 2022
Study Completion Date: 28 Oct 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

The First Affiliated Hospital, Sun Yat-sen University, The Third Affiliated Hospital, Sun Yat-sen University, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, The First Affiliated Hospital of Nanchang University, Henan Provincial People's Hospital, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Wuhan Union Hospital of China, Peking University First Hospital, The First Affiliated Hospital of Anhui Medical University, Shengjing Hospital

Inclusion and exclusion criteria